Skip to main content

Table 1 Concise overview table of patient characteristics, tissue collection and data metrics of this study

From: High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification

Patient Histology FIGO stage* N of samples Sample site Tissue type Sample_ID° Total n cells Median n genes/cell Median n UMIs/cell Sequencing saturation
Patient 1 HGSTOC IIIC 5 Omentum Tumour P1TOm 1403 3109 11,544 73.50%
Omentum Non-tumour P1NOm 879 2751 10,090 82.50%
Peritoneum Non-tumour P1NP 1045 1162 2867 93.90%
Peritoneum Tumour P1TP 1249 1192 2958 92.90%
Ovary Tumour P1TOv 1419 3407 12,854 78.20%
Patient 2 HGSTOC IVB 1 Peritoneum Tumour P2TP 2482 2064 7133 81.10%
Patient 3 HGSTOC-CCC IVB 1 Peritoneum Tumour P3TP 3537 2838 9311 63.00%
Patient 4 HGSTOC IC1 2 Ovary Tumour P4TOv 395 2119 7896 87.50%
Ovary Non-tumour P4NOv 3044 1527 5061 67.50%
Patient 5 HGSTOC IVB 1 Peritoneum Tumour P5TP 1343 4610 23,655 74.70%
Patient 6 HGSTOC IIIC 1 Peritoneum Tumour P6TP 2060 4008 20,327 62.90%
Patient 7 HGSTOC IVB 1 Peritoneum Tumour P7TP 1627 1526 5348 63.60%
  1. HGSTOC high-grade serous tubo-ovarian carcinoma, CCC clear cell carcinoma, N number, UMI Unique Molecular Identifier
  2. * FIGO stage = disease stage determined by the International Federation of Gynaecology and Obstetrics (FIGO) 2014
  3. ° Sample_ID = code attributed to every sample containing 3 elements: (1) patient number (P1–P7), (2) tissue type (T = tumour, N = non-tumour) and (3) sampling site (Om = omentum, Ov = ovary, P = peritoneum)